BSI’s goal is to make QS-21 accessible to a wider range of vaccines and populations, particularly in low-income countries.
The launch of Denarase High Salt GMP-grade marks a significant milestone in c-LEcta’s commitment to providing innovative solutions for the biopharmaceutical industry. This engineered enzyme ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback